Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-14 4:19 pm Sale | 2024-09-30 | 13G | Bolt Biotherapeutics, Inc. BOLT | CITADEL ADVISORS LLC | 0 0.000% | -2,458,958 (Position Closed) | Filing History |
| 2024-02-14 4:57 pm Sale | 2023-12-31 | 13G | Bolt Biotherapeutics, Inc. BOLT | CITADEL ADVISORS LLC | 2,458,958 6.500% | -293,237 (-10.65%) | Filing History |
| 2024-02-14 4:00 pm Purchase | 2023-12-31 | 13G | Bolt Biotherapeutics, Inc. BOLT | TANG CAPITAL PARTNERS LP | 3,652,244 9.600% | 919,994 (+33.67%) | Filing History |
| 2024-02-13 5:00 pm Sale | 2023-12-31 | 13G | Bolt Biotherapeutics, Inc. BOLT | Vivo Capital VIII LLC | 2,073,005 5.500% | -200,000 (-8.80%) | Filing History |
| 2024-02-12 9:41 pm Unchanged | 2024-02-12 | 13D | Bolt Biotherapeutics, Inc. BOLT | Pivotal bioVenture Partners Fund I L.P. | 3,058,419 8.100% | 0 (Unchanged) | Filing History |
| 2023-04-20 4:13 pm Purchase | 2023-04-10 | 13G | Bolt Biotherapeutics, Inc. BOLT | TANG CAPITAL PARTNERS LP | 2,732,250 7.200% | 2,732,250 (New Position) | Filing History |
| 2023-02-14 08:02 am Sale | 2022-12-31 | 13G | Bolt Biotherapeutics, Inc. BOLT | CITADEL ADVISORS LLC | 2,752,195 7.300% | -60,254 (-2.14%) | Filing History |
| 2023-02-13 12:36 pm Sale | 2022-12-31 | 13G | Bolt Biotherapeutics, Inc. BOLT | SUVRETTA CAPITAL MANAGEMENT LLC | 0 0.000% | -2,230,250 (Position Closed) | Filing History |
| 2023-01-04 4:20 pm Sale | 2022-12-29 | 13D | Bolt Biotherapeutics, Inc. BOLT | Novo Holdings A/S | 0 0.000% | -2,534,465 (Position Closed) | Filing History |
| 2022-12-28 2:51 pm Sale | 2022-12-21 | 13D | Bolt Biotherapeutics, Inc. BOLT | Novo Holdings A/S | 2,534,465 6.700% | -1,169,526 (-31.57%) | Filing History |
| 2022-09-30 4:48 pm Unchanged | 2022-09-27 | 13D | Bolt Biotherapeutics, Inc. BOLT | Novo Holdings A/S | 3,703,991 9.800% | 0 (Unchanged) | Filing History |
| 2022-07-15 4:01 pm Sale | 2022-07-13 | 13D | Bolt Biotherapeutics, Inc. BOLT | Novo Holdings A/S | 3,703,991 9.800% | -800,000 (-17.76%) | Filing History |
| 2022-05-16 4:31 pm Sale | 2022-05-16 | 13G | Bolt Biotherapeutics, Inc. BOLT | RA CAPITAL MANAGEMENT L.P. | 0 0.000% | -2,378,325 (Position Closed) | Filing History |
| 2022-02-14 06:12 am Sale | 2021-12-31 | 13G | Bolt Biotherapeutics, Inc. BOLT | CITADEL ADVISORS LLC | 2,812,449 7.500% | -129,558 (-4.40%) | Filing History |
| 2021-11-29 4:39 pm Purchase | 2021-11-18 | 13G | Bolt Biotherapeutics, Inc. BOLT | SUVRETTA CAPITAL MANAGEMENT LLC | 2,230,250 6.000% | 2,230,250 (New Position) | Filing History |
| 2021-11-22 4:03 pm Unchanged | 2021-11-15 | 13D | Bolt Biotherapeutics, Inc. BOLT | Novo Holdings A/S | 4,503,991 12.000% | 0 (Unchanged) | Filing History |
| 2021-08-13 5:02 pm Purchase | 2021-02-21 | 13D | Bolt Biotherapeutics, Inc. BOLT | Pivotal bioVenture Partners Fund I L.P. | 3,058,419 8.400% | 1,166,952 (+61.70%) | Filing History |
| 2021-04-07 4:30 pm Purchase | 2021-04-01 | 13G | Bolt Biotherapeutics, Inc. BOLT | RA CAPITAL MANAGEMENT L.P. | 2,378,325 6.500% | 2,378,325 (New Position) | Filing History |
| 2021-02-19 4:03 pm Purchase | 2021-02-09 | 13G | Bolt Biotherapeutics, Inc. BOLT | CITADEL ADVISORS LLC | 2,942,007 8.100% | 2,942,007 (New Position) | Filing History |
| 2021-02-18 4:50 pm Purchase | 2021-02-09 | 13G | Bolt Biotherapeutics, Inc. BOLT | Vivo Capital VIII LLC | 2,273,005 6.600% | 2,273,005 (New Position) | Filing History |